- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 251/50 - Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals
Patent holdings for IPC class C07C 251/50
Total number of patents in this class: 21
10-year publication summary
|
5
|
2
|
0
|
1
|
3
|
1
|
2
|
4
|
0
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4879 |
5 |
| Sumitomo Chemical Company, Limited | 9031 |
3 |
| Syngenta Participations AG | 1907 |
2 |
| Medshine Discovery Inc. | 601 |
2 |
| ReNAgade Therapeutics Management Inc. | 44 |
2 |
| Bayer Cropscience AG | 2051 |
1 |
| Fondazione IRCCS ?Instituto Nazionale dei Tumori? | 1 |
1 |
| Oscotec Inc. | 28 |
1 |
| Shenyang Research Institute of Chemical Industry Co., Ltd. | 39 |
1 |
| Sinochem Corporation | 106 |
1 |
| Takasago International Corporation | 404 |
1 |
| Takasago International Corporation (USA) | 16 |
1 |
| Other owners | 0 |